image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
4bbe442954ab7528ec14558ce4cce88c936bf64d593478e140df4af314982427.png | simple | <table><tr><td>Amino Acid</td><td>mg/g Crude Protein</td><td>FAO Report mg/g Protein <sup>a</sup></td><td>AAS</td></tr><tr><td>histidine</td><td>38.6 ± 2.3</td><td>16</td><td>2.41</td></tr><tr><td>isoleucine</td><td>54.5 ± 0.0</td><td>30</td><td>1.82</td></tr><tr><td>leucine</td><td>102.1 ± 0.1</td><td>6... |
d39466004cbf68fad9f51f7f9c56163f0ba8fdbcd6ba9ae578e74c97d1366fd9.png | simple | <table><tr><td>Name</td><td>Company</td><td>Catalog number</td><td>Antibody concentration</td></tr><tr><td>DAB2IP</td><td>Abcam</td><td>ab87811</td><td>1 : 1000 or 1 : 200</td></tr><tr><td>E-cadherin</td><td>Cell Signaling Technology</td><td>3195</td><td>1 : 500</td></tr><tr><td>Vimentin</td><td>Cell Signaling Technolo... |
2d9f6a615a3891c84134293f3cd9bd08be23abf8cd2fb1d13926374221b22c8d.png | complex | <table><tr><td rowspan="2">Intentions *</td><td colspan="5">Male (<i>n</i>)</td><td colspan="6">Female (<i>n</i>)</td></tr><tr><td>5</td><td>4</td><td>3</td><td>2</td><td>1</td><td>5</td><td>4</td><td>3</td><td>2</td><td>1</td><td><i>p</i></td></tr><tr><td>After the delivery, I would not try to establish breastfeeding.... |
8c23bcdced3b9cd33018063ec840857cd2c629205b4a9ae5f3fe41856c29b144.png | simple | <table><tr><td></td><td>Estimate</td><td>Standard Error</td><td>Chi-Square (df = 1) or t-value</td><td>Odds Ratio</td><td>95% Confidence Interval</td><td>p-value</td></tr><tr><td>W1 drinking predicting stroke</td><td>-0.31</td><td>0.10</td><td>10.8</td><td>0.73</td><td>0.61–0.88</td><td>0.001</td></tr><tr><td>W1 ... |
1460ce6985beef2d512ce7a02207eab4ea5d969effb6920e73cc4d09e91b2a85.png | complex | <table><tr><td colspan="4">WNV-L vs. E</td><td colspan="4">CHIKV-L vs. E</td></tr><tr><td>Symbol</td><td>Entrez gene name</td><td>Log<sub>2</sub> fold change</td><td><i>P</i>-value</td><td>Symbol</td><td>Entrez gene name</td><td>Log<sub>2</sub> fold change</td><td><i>P</i>-value</td></tr><tr><td>Lcn2</td><td>Lipocalin ... |
e8931ba2069a2e9c61ffe2a5bd335d08a0e50c4792904dec98cd8bdf41133020.png | complex | <table><tr><td></td><td colspan="10"><i>Pol</i> subtype</td></tr><tr><td><i>Env</i> subtype</td><td>A</td><td>B</td><td>C</td><td>D</td><td>F</td><td>G</td><td>H</td><td>01_AE</td><td>02_AG</td><td>UA</td></tr><tr><td>A-like</td><td>59</td><td></td><td></td><td>3</td><td>1</td><td>3</td><td></td><td>1</td><td>71</td><t... |
5535753c8bc884bdd0efc400bc2badc105fd444c3f2d715fb6b6f69af12b8ef2.png | simple | <table><tr><td></td><td>Range</td><td>Mean (SD)</td></tr><tr><td>Temperature, centigrade</td><td>36–38</td><td>37 ± 0.5</td></tr><tr><td>Systolic blood pressure, mmHg</td><td>100–190</td><td>140 ± 24</td></tr><tr><td>Diastolic blood pressure, mmHg</td><td>60–140</td><td>86 ± 22</td></tr... |
6435b7e0a3f2a0e5ac455ce8459047c8fe760d2696e67b5cfe1d0c6a17e846c8.png | complex | <table><tr><td colspan="3"><i>FRR</i> (%)</td></tr><tr><td>User</td><td>EEG</td><td>Multi-Task</td></tr><tr><td>1</td><td>6.00</td><td>2.00</td></tr><tr><td>2</td><td>0.00</td><td>0.00</td></tr><tr><td>3</td><td>2.00</td><td>0.00</td></tr><tr><td>4</td><td>12.00</td><td>16.00</td></tr><tr><td>5</td><td>16.00</td><td>8.... |
066a25e7107fba79e621716a8dc8d073bb5408bda2874828f40d48de53316ffa.png | complex | <table><tr><td rowspan="3">Variables</td><td colspan="5">HOMA-IR quartiles</td></tr><tr><td>Q1</td><td>Q2</td><td>Q3</td><td>Q4</td><td><i>p</i> for linear</td></tr><tr><td>(<1.13)</td><td>(1.13–1.65)</td><td>(1.65–2.65)</td><td>(>2.65)</td><td>trend</td></tr><tr><td><i>Age (years)</i></td><td>10.3 &#... |
032738550710d1c7a84243d90d6a84f04c43ccc2c68b95dba351ae5071aecbe1.png | simple | <table><tr><td>Breeds</td><td>MAF ± s.d.</td><td>Ho ± s.d.</td><td>He ± s.d.</td><td><i>F</i>± s.d.</td><td>N<sub>e</sub></td></tr><tr><td>Valle del Belice</td><td>0.290 ± 0.003</td><td>0.364 ± 0.126</td><td>0.379 ± 0.155</td><td>0.055 ± 0.150</td><td>369</td></tr><tr><td>Comisan... |
a077e393df89a339c5e3ef2229589523e044b9ff4ead8ae04652772b11158847.png | simple | <table><tr><td><i>Peg</i></td><td><i>Coupled Score</i></td><td><i>Abstract Coupling Score</i></td><td><i>Function</i></td></tr><tr><td>fig|243277.1.peg.316</td><td>6</td><td>0.38</td><td>Translation elongation factor Tu</td></tr><tr><td>fig|243277.1.peg.318</td><td>39</td><td>0.65</td><td>Transcription antitermination ... |
905e6b01552394c651df9a617c8a19203fe57d963faeceefac903b06534fcebc.png | simple | <table><tr><td>Component score</td><td>SOFA</td><td>MOD</td></tr><tr><td>Cardiovascular</td><td>56%</td><td>18%</td></tr><tr><td>Respiratory</td><td>43%</td><td>23%</td></tr><tr><td>Coagulation</td><td>6%</td><td>4%</td></tr><tr><td>Renal</td><td>0.5%</td><td>0.5%</td></tr><tr><td>Hepatic</td><td>1%</td><td>0%</td></tr... |
f4739a4ef2cc53858da1b212d2de0d0dbf07789092d873e05011f35bea5509cf.png | complex | <table><tr><td rowspan="2">Specimens ID</td><td colspan="4">Multiplex</td><td colspan="4">WHO</td></tr><tr><td>Flu A</td><td>H7</td><td>N9</td><td>RP</td><td>Flu A</td><td>H7</td><td>N9</td><td>RP</td></tr><tr><td>20130405-5</td><td>24.26 ± 0.35<sup>a</sup></td><td>24.45 ± 0.21</td><td>25.03 ± 0.3</td><t... |
297a37acc88ca8ca520e5de801e031f1817a5409fb2a7333880efadc59113587.png | complex | <table><tr><td></td><td colspan="2">Full study population</td><td colspan="5">Nested case-control samples for different case-control ratios</td></tr><tr><td></td><td>DVT +</td><td>DVT-</td><td>Cases</td><td colspan="4">Controls</td></tr><tr><td>Test results</td><td>n = 289</td><td>n = 1006</td><td>n = 289</td><td>1:1n ... |
6509683cc84c1b92dd9f729bb2b6a876d41698311d0781521b7fe0e333c830e5.png | complex | <table><tr><td><i>Plan</i></td><td><i>Plane</i></td><td><i>6 MV Gamma Passing Rate (%)</i></td><td><i>Plane</i></td><td><i>18 MV Gamma Passing Rate (%)</i></td></tr><tr><td>I1 Multitarget</td><td>Isocenter</td><td>93.9</td><td>Isocenter</td><td>95.9</td></tr><tr><td>I2 Mock Prostate</td><td>Isocenter</td><td>91.7</td><... |
4ae25d2a65dc77f41d628dbfa418a0a56761a22c0ae3a20cb0c5922d767e74a3.png | complex | <table><tr><td>Transcription factor family</td><td colspan="2">L1 vs. L2 (transcript) Up-or down-regulated</td><td colspan="2">L1 vs. L3 (transcript) Up-or down-regulated</td><td colspan="2">L2 vs. L3 (transcript) Up-or down-regulated</td></tr><tr><td></td><td>Up</td><td>Down</td><td>Up</td><td>Down</td><td>Up</td><td>... |
101cdfdc69501b7e1b6f6787c807b5a7c325f14fa11db990f1a7a04702214b50.png | complex | <table><tr><td>RDQ Scale</td><td colspan="2">Effect size</td><td colspan="2">Standardized response mean</td></tr><tr><td></td><td>Esomeprazole</td><td>Placebo</td><td>Esomeprazole</td><td>Placebo</td></tr><tr><td>Heartburn</td><td>2.05</td><td>0.85</td><td>1.52</td><td>0.74</td></tr><tr><td>Regurgitation</td><td>1.36</... |
162d54cd39327270a11d6cb62707a919cfb212e6072f6cf309b9a330859f37d5.png | complex | <table><tr><td></td><td colspan="3">Median $ (IQR)</td></tr><tr><td></td><td>MostPopular1</td><td>First-linequality-assured ACT</td><td>Oral Artemisinin Monotherapy</td></tr><tr><td>Benin<sup>2</sup></td><td>0.65 <sup>a </sup>(0.43, 1.08) N = 462</td><td>3.24 <sup>b </sup>(1.94, 5.77) N = 216</td><td>8.10 (8.07, 10.45)... |
7dd7c8a9a8daf28191c26ea351d402572713e3081378160d0afc4d6dbd16cbac.png | complex | <table><tr><td>Subtypes of epilepsy</td><td>T. gondiin (%)</td><td>Pvalue</td><td>Toxocaran (%)</td><td>Pvalue</td></tr><tr><td>Idiopathic</td><td>16/117 (13.67)</td><td rowspan="3">0.8</td><td>25/117(21.36)</td><td rowspan="3">0.2</td></tr><tr><td>Febrile seizure(Special syndrome)</td><td>2/10 (20)</td><td>0/10(0)</td... |
910c31ed505cf4e16b15020417cd62a7e975c5b42d96660564fad4b3fd0fcd83.png | simple | <table><tr><td>Anamnestic and clinicalFeatures of red flags</td><td>Sign and symptoms ofSpecific shoulder pain</td></tr><tr><td>Fever, shivering, changes in body temperature overnight, diaphoresis, nausea, unexplainable sweating overnight, vomiting, sphincteric complaints, diarrhoea, paleness, fatigue, lurching, fainti... |
8e11f27ded25eb4e1e5470e2262445211cc049fdc8c5026ccdf655c7aadc0f11.png | simple | <table><tr><td>Measure(n=)</td><td>HIF-1αH-scoreMean(± sd)</td><td>GLUT-1H-scoreMean(± sd)</td><td>CA-IXH-scoreMean(± sd)</td><td>MVDfrequencyhigh(%)</td><td>CK 5/6frequencypositive(%)</td><td>VEGF-Apg/mlMean(± sd)</td><td>IGF-1ng/mlMean(± sd)</td></tr><tr><td>Nodal status<sup>1</sup></td>... |
80e89249b75fa7745b3b92fd472f41e4dbb724d387c781189364459c8128479a.png | simple | <table><tr><td></td><td>ρ</td><td>ρ-partial</td></tr><tr><td>Baseline disability</td><td>0.46<sup>‡</sup></td><td></td></tr><tr><td>Age</td><td>0.26<sup>‡</sup></td><td>0.28<sup>‡</sup></td></tr><tr><td>Somatization</td><td>0.40<sup>‡</sup></td><td>0.23<sup>‡</sup></td></tr><tr><... |
67d9a122fa2b71c585df3d4900d1f0200a91d695f0234379bc11c688900c40cd.png | simple | <table><tr><td> </td><td><i>Primary Rd until progression (</i>n<i>=9)</i></td><td><i>Primary Rd stopped before progression (</i>n<i>=11)</i></td><td><i>Primary Rd stopped with progression and restarted (</i>n<i>=5)</i></td><td><i>Rd induction followed by SCT (</i>n<i>=8)</i></td></tr><tr><td>Age, years, median (range)<... |
328bbed101b682a059de40ac5cc97baa2cf58280c8e4308eb764cca974fd666f.png | complex | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Control M (SD)</td><td rowspan="2">MCI M (SD)</td><td rowspan="2">AD M (SD)</td><td rowspan="2">P<sup>1</sup></td><td>P*</td><td> </td><td>P*</td><td> </td><td>P*</td></tr><tr><td>Control × MCI</td><td> </td><td>Control × AD</td><td> </td><td>MCI × ... |
5741eaf6b90237ad17a282b5a48ffa9f80c407e55b04ea2b662ae49cc093314c.png | complex | <table><tr><td>Input</td><td colspan="3">Membership Function</td></tr><tr><td>RSSI Level</td><td>Weak</td><td>Medium</td><td>Strong</td></tr><tr><td>Number of Neighbours</td><td>Low</td><td>Medium</td><td>High</td></tr><tr><td>Distance to each neighbour</td><td>Near</td><td>Medium</td><td>Far</td></tr></table> |
46544ca7b0f480ccdeadfeeea0f127320e2ac6856f6fb9d7336c5425b79a04dc.png | complex | <table><tr><td>Characteristic (<i>N =</i> 148)</td><td>Number</td><td>Percent</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td> Female</td><td>126</td><td>85.1</td></tr><tr><td>Grade level</td><td></td><td></td></tr><tr><td> Freshman</td><td>36</td><td>24.3</td></tr><tr><td> Sophomore</td><td>38</td><td>25.7<... |
1e7477e8a4e79c12d9ba99db7c4a72a9f9bed84e364e9313026dca88c304a622.png | simple | <table><tr><td>Degrees of freedom</td><td>90%</td><td>95%</td></tr><tr><td>1</td><td>2.71</td><td>3.84</td></tr><tr><td>2</td><td>4.61</td><td>5.99</td></tr><tr><td>3</td><td>6.25</td><td>7.81</td></tr><tr><td>4</td><td>7.78</td><td>9.49</td></tr></table> |
6b4d1cc752db497e4d985150024f5ad989fe8813f6e52ce0029d9dee5789efd1.png | simple | <table><tr><td>Scale</td><td>Factor</td><td>N</td><td>%</td></tr><tr><td>SCL-90-R</td><td>Without psychopathology > 0.99</td><td>62</td><td>44.6</td></tr><tr><td></td><td>Somatization (SOM) > 0.99</td><td>47</td><td>33.8</td></tr><tr><td></td><td>Obsessive-compulsive (OC) > 0.99</td><td>43</td><td>30.9</td></t... |
3bccc8d9e82a743d16f3315e3d83c73139338e208bb11708765d524bbaa8fb05.png | simple | <table><tr><td>Clade</td><td>Combined-data and mtDNA</td><td>Combined-data and nucDNA</td><td>mtDNA and nucDNA</td></tr><tr><td>Balistid fish</td><td>16%</td><td>24%</td><td>11%</td></tr><tr><td>Scarine fish</td><td>83%</td><td>63%</td><td>50%</td></tr><tr><td>Hemiphractid frogs</td><td>64%</td><td>52%</td><td>30%</td>... |
be7e1c255029bde7cda06ae6e238b0cdd8a1aac11f07e85df06184e09d0a0c13.png | complex | <table><tr><td></td><td>Mean</td><td>Sd</td><td>Median</td><td>Iqr</td><td><i>P</i>-value</td></tr><tr><td colspan="6">Sex</td></tr><tr><td> M</td><td>118.17</td><td>18.37</td><td>117.5</td><td>17</td><td>0.0326*</td></tr><tr><td> F</td><td>112.46</td><td>19.13</td><td>114</td><td>20</td><td></td></tr><tr><td colspan="... |
4bab918b39dd5e367e5cecea23884918eaa587761664b88272ede27fb2d5a2ff.png | simple | <table><tr><td>Human region</td><td>Avian region</td><td>Reference</td></tr><tr><td>Nucleus accumbens (nAc)</td><td>Nucleus accumbens (nAc)</td><td>Balint and Csillag (2007), Husband and Shimizu (2011)</td></tr><tr><td>Ventral tegmental area (VTA)</td><td>Ventral tegmental area (VTA)</td><td>Bottjer (1993), Reiner et a... |
49359ce3f5daf4139004cef752c55d7ed8b66ff0372ce9ea67655efea17d0fae.png | complex | <table><tr><td></td><td>2007</td><td colspan="5">2012</td><td></td></tr><tr><td></td><td></td><td colspan="5">Exposed to the intervention</td><td></td></tr><tr><td rowspan="2"></td><td rowspan="2"></td><td>Never</td><td>Once</td><td>Twice or more</td><td rowspan="2">Total</td><td rowspan="2"><i>p*</i></td><td rowspan="... |
27342fd9e5ce2f17e5f2853df36d74859aa5636e90f7a9fbf3238ece39dfc004.png | simple | <table><tr><td> </td><td>Mortality 2003</td><td>Mortality 2010</td><td>Unadjusted HR</td><td>Adjusted HR *</td><td>Adjusted HR †</td></tr><tr><td> </td><td>N/total (%)</td><td>N/total (%)</td><td>(95% CI)</td><td>(95% CI)</td><td>(95% CI)</td></tr><tr><td>Total</td><td>333/1624 (20.5)</td><td>488/3809 (12.8)</td>... |
7922adb89048dcd95cc2b3449f075661df3cb51facc29134c46b3897f0a222fe.png | simple | <table><tr><td>Study</td><td>Type of study</td><td>No. of patients receiving short-term radiotherapy (%)</td><td>Experimental group^No of DR/No of patients(%)</td><td>Control groupNo of DR/No of patients (%)</td><td><i>P</i> value</td></tr><tr><td>Nowacki et al. (2004) [4]</td><td>Randomized</td><td>78 (40.4)</td><td>1... |
ebcc7b910d91f414f46b368af72afdc42c422ddb697601f2fba17506e8f94f0d.png | simple | <table><tr><td>Factor</td><td>Coefficient</td><td><i>Z</i></td><td><i>P</i></td></tr><tr><td>Range (native)</td><td>1.122</td><td>3.16</td><td>0.0016*</td></tr><tr><td>Fish (present)</td><td>0.106</td><td>0.25</td><td>0.8000</td></tr><tr><td>Food Quality (low)</td><td>1.128</td><td>3.18</td><td>0.0015*</td></tr><tr><td... |
a69638a84e030ba5621c0bff1ea17c475c167c4173ca9d2c847e634385125a2d.png | complex | <table><tr><td> </td><td colspan="4">Number of parathyroid glands in resected specimen</td><td colspan="2"><i>P</i>-value</td></tr><tr><td>Variable</td><td>0 (A) N = 364</td><td>1(B) N = 80</td><td>2 or more (C) N = 10</td><td>Total n = 454</td><td>A versus B</td><td>B versus C</td></tr><tr><td>CND</td><td> </td><td> <... |
95af753059c54a6745ead8b12ebca50699dc47f48ded7203dbda49cf4571ca5c.png | complex | <table><tr><td colspan="2">EGFR/ACTB (cutoff 0.05)</td><td colspan="5">EFEMP1/ACTB (cutoff 0.06)</td></tr><tr><td colspan="2">All gliomas<sup>a</sup></td><td colspan="2">All gliomas</td><td>GBM(95 pts, 88 died)</td><td>AA(36 pts, 23 died)</td><td>OT(35 pts, 18 died)</td></tr><tr><td>1.0 (0.7, 1.4)</td><td>P = 0.85</td>... |
25d438393e0b59e8bd5f2c7f1692074c77595703bac48ecbaefb0794a65ae6fc.png | complex | <table><tr><td rowspan="2">Carbon source</td><td rowspan="2">Dry weight of mycelial mat (mg/flask)</td><td rowspan="2">Protein content (mg/ml)</td><td colspan="3">Cellulase</td></tr><tr><td><sup>a</sup>FPase (FPU/ml)</td><td><sup>b</sup>CMCase (U/ml)</td><td><sup>c</sup>Β-glucosidase (U/ml)</td></tr><tr><td>Sarbos... |
c47fa62011d2415bfcb6e4d33673d2c1c201d1f99ab1f084328938a17e73cb69.png | complex | <table><tr><td rowspan="2">Source</td><td rowspan="2">WT categories</td><td rowspan="2">Sample size</td><td colspan="2">HR (95%CI)</td></tr><tr><td>OS</td><td>DFS/RFS/EFS</td></tr><tr><td rowspan="2">Pronzato <i>et al</i>. [13] 1989</td><td>≤35 days</td><td>116</td><td>Reference</td><td>−</td></tr><tr><td>&... |
5bdddfacefc37a5806c147b5d29f408960630240fdde630f069d5b3f47aea7ea.png | complex | <table><tr><td></td><td>Difficulty</td><td>SE</td><td colspan="4">Classified groups for DIF</td><td colspan="2">MNSQ</td></tr><tr><td></td><td>Logits</td><td>Logits</td><td><i>Gender</i></td><td><i>Education</i></td><td><i>Age</i></td><td><i>Disease</i></td><td><i>Outfit</i></td><td><i>Infit</i></td></tr><tr><td colspa... |
e5142b67824a78e6313e3ca17dbfc1f7ba9f76428ef49c2802a8021bef4bb3c3.png | complex | <table><tr><td rowspan="2">Study groups</td><td colspan="3">No. tested/no. (%) seropositive</td></tr><tr><td>Females</td><td>Males</td><td>Total</td></tr><tr><td>KNP employees with outdoor activity</td><td>5/2 (40)</td><td>23/12 (52.2)</td><td>28/14 (50.0)</td></tr><tr><td>KNP employees with indoor activity</td><td>18/... |
a578072286f2bfe36de24b657a6b64798886151e8fc016d5d7575c172fb656a5.png | simple | <table><tr><td>Thyroid lesions simulating a squamoid pattern</td><td>Differential features</td></tr><tr><td>Pure squamous cells carcinoma</td><td>(i) Entirely composed of squamous cells; (ii) no evidence of another type of thyroid carcinoma in close proximity.</td></tr><tr><td>Primary head and neck squamous cell carcin... |
724d6cde3059b1e5f72a3c02db0e1311133686ceb4069cf3dc849e186d1a0cc8.png | complex | <table><tr><td rowspan="3"><i>Terms of Delivery</i></td><td colspan="4"><i>Trichomonas vaginalis infection</i></td><td rowspan="3"><i>P-value</i></td></tr><tr><td colspan="2">Study group (positive cases)</td><td colspan="2">Control group (negative cases)</td></tr><tr><td>No.</td><td>(%)</td><td>No.</td><td>(%)</td></tr... |
6cbba4646d94def7de14c3bce2974585960be875ffa59e61efcd82127fd8ee16.png | complex | <table><tr><td rowspan="2">Assumptions</td><td colspan="4">Projected reduction in diabetes prevalence compared to no intervention</td></tr><tr><td>Moderate-risk [millions]</td><td>High-risk [millions]</td><td>Population [millions]</td><td>Combined [millions]</td></tr><tr><td colspan="5">Base case assumptions:</td></tr>... |
4c07617c1a54ed4d77de2bb45457c8beabe00dcf20c959b29d932ff7387db154.png | complex | <table><tr><td> </td><td> </td><td>Coefficient (95%CI of coefficient)</td><td>P-value</td></tr><tr><td rowspan="5">Axial length (mm)</td><td>Age (years)</td><td>−0.007 (−0.012 to −0.003)</td><td><0.001</td></tr><tr><td>Sex (male/female)</td><td>0.111 (0.035 to 0.186)</td><td>0.004</td></tr><tr><td>... |
bf800c00b2ac368a62a6678739240414350244d1f5038148d4e01eddcf770740.png | complex | <table><tr><td></td><td colspan="7">Target head angle (degrees)</td></tr><tr><td></td><td>−80</td><td>−60</td><td>−40</td><td>−20</td><td>0</td><td>20</td><td>40</td></tr><tr><td colspan="8">Pitch experiment</td></tr><tr><td>Qualitative descriptions</td><td>11</td><td>12</td><td>12</td><td>11</t... |
bf37ad9e9e4039e88668875f19c55b4835ea361c8a145d0b62905c1e2b8f8c41.png | complex | <table><tr><td></td><td>Ofloxacin</td><td colspan="2">Injectable drugs</td><td>TotalResistance to either Fluoroquinolone or injectable drugsN (%)</td></tr><tr><td></td><td>OfloxacinR, n (%)</td><td>KanamycinR, n (%)</td><td>CapreomycinR, n (%)</td><td></td></tr><tr><td>New MDR patients (<i>n</i> = 5)</td><td>0 (0)</td>... |
7445c6d458607ed471eee32dc6a2b7c3909b01e5ae51af2ee66864c764908539.png | simple | <table><tr><td>Ectoparasite</td><td> Postlactating females</td><td> Nonreproductive females</td></tr><tr><td></td><td>(<i>n</i> = 17)</td><td>(<i>n</i> = 97)</td></tr><tr><td><i>Spinturnix americanus</i></td><td>41.2%, 0.5 (0.7, 0–2)</td><td>38%, 0.7 (1.2, 0–5)</td></tr><tr><td><i>Myodopsylla insignis</i></... |
f23c799c1365bc27ce9d836632777589d275cc3664f9220d18148008638b19ad.png | complex | <table><tr><td>Finding</td><td>Illustrating data</td></tr><tr><td>Localized changes, with minimal impact on wider clinical systems or resource-allocation decisions, may be sustained relatively easily</td><td><i>Case D</i>: ‘The long term viability is very, very strong, it's viewed as an essential service, the pat... |
7d4a134bcacd225568c66932266fcabfe2ead6f8e98f1017f546a1dc94d55489.png | simple | <table><tr><td><i>No.</i></td><td><i>Themes</i></td><td><i>OSPE</i></td><td><i>OSCE</i></td><td><i>Frequency</i></td><td><i>Total</i></td></tr><tr><td>1.</td><td><i>Curriculum</i></td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td> Syllabus</td><td>+</td><td>++</td><td>3</td><td>7</td></tr><tr><td> </td... |
17029d86268870618e765d54bc7a1f76d35470882b42caa5076bbf5e9da712a2.png | complex | <table><tr><td></td><td colspan="3">Intention to treat</td><td colspan="3">Modified intention to treat</td></tr><tr><td></td><td>Antibiotic treatmentn = 22</td><td>No antibiotic treatmentn = 36</td><td><i>P </i>value</td><td>Antibiotic treatmentn = 18</td><td>No antibiotic treatmentn = 26</td><td><i>P </i>value</td></t... |
1419b03df6458ee6e5d54931cd53374526853019363efc48b43f7227b0f583df.png | simple | <table><tr><td>Site</td><td>Ever smoked cigarettes, even one or two puffs</td><td>Ever smokers who initiated smoking before age 10</td><td>Never smokers susceptible to initiate smoking in the next year</td></tr><tr><td>Huancayo, 2000</td><td>47.1 (40.9–53.5) (n = 963)</td><td>18.1 (13.6–23.6) (n = 429)</td>... |
c17e4be7f9acfa1b3f15c820171fd26dc5f15eb17837d4ffbf070c9ba7d4ae26.png | complex | <table><tr><td></td><td colspan="2">Response rate</td><td colspan="2">NR</td></tr><tr><td></td><td>Prosody+</td><td>Prosody−</td><td>Prosody+</td><td>Prosody−</td></tr><tr><td>Healthy controls (CI 95%)</td><td>96 ± 4 (94, 98)</td><td>84 ± 7 (81, 87)</td><td>3 ± 4(2, 2)</td><td>10 ± 7(7, ... |
516ae0c6d76f7b9a6d5345af55af644c356dc2d99da3876cc8b4a8a3eada9544.png | simple | <table><tr><td>Clinical trials</td><td>Interventions</td><td>URL</td></tr><tr><td>124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study</td><td>Radiation: 124I-MIBG (no-carrier added)Radiation: 124I-MIBG (carrier added)</td><td>https://ClinicalTrials.... |
021dbabad68a7ad792b14d061ed0531423bd4869aade3007fa149daf2b45e637.png | complex | <table><tr><td>Capacity areas/skills for HPSR+A</td><td>Proportion of staff requiring additional training (n = 123), n (%)</td></tr><tr><td>HPSR+A technical skills and conceptual underpinnings,</td><td></td></tr><tr><td> e.g. what is HPSR+A and what constitutes HPSR+A approaches to research and teaching</td><td>101 (82... |
5f878d53217ae4423cf49df0789c433e72e7fe65c36e96a96f1865433f9ec60a.png | simple | <table><tr><td>Variable</td><td>n</td><td>%</td><td>SE (<i>P</i>)</td></tr><tr><td>Sex</td><td></td><td></td><td></td></tr><tr><td> Male</td><td>207</td><td>62.9</td><td>2.67</td></tr><tr><td> Female</td><td>121</td><td>36.8</td><td>2.66</td></tr><tr><td>Age (y)</td><td></td><td></td><td></td></tr><tr><td> <40</td><... |
4a9197a72bdd3845b64a72d3e5eabc783c3061d278531812f891899b5df9f5d0.png | complex | <table><tr><td rowspan="2">Variables</td><td>Cases</td><td>Controls</td><td>Adjusted OR ratio</td><td rowspan="2">P value</td></tr><tr><td>No. (%)</td><td>No. (%)</td><td>(95% Cl)</td></tr><tr><td>Family size (mean 95% Cl)</td><td>5.8(5.3-6.4)</td><td>4.8(4.4-5.1)</td><td>1.359(1.026-1.799)</td><td>0.032</td></tr><tr><... |
e7b94328afe7a4805b2aa03fe1a4f0ef063b12c90fda2ae99a3dbaee3c58dee9.png | complex | <table><tr><td rowspan="2">Treatment</td><td rowspan="2">Dose mg kg<sup>−1</sup></td><td>Cotton pellet granuloma</td></tr><tr><td>Weight of pellets Mean ± SEM</td></tr><tr><td>Control</td><td>0.3 mL</td><td>51.73 ± 2.35</td></tr><tr><td>Indomethacin</td><td>10</td><td>19.82 ± 2.52 (61.68)<sup>b</su... |
38faa325fa1ef7142f47f0185c8d79492a36b15bce9c5663158995af6ed5bdfb.png | simple | <table><tr><td>Characteristic</td><td>All</td><td>LGE [IQR]</td><td>Non-LGE [IQR]</td><td>p value</td></tr><tr><td></td><td>(<i>n </i>= 20)</td><td>(<i>n </i>= 8)</td><td>(<i>n </i>= 12)</td><td></td></tr><tr><td>Age (years)</td><td>77 [65-82]</td><td>75 [70-80]</td><td>78 [65-84]</td><td>0.4</td></tr><tr><td>Female se... |
69f4185d1b5e258904f268af7655885a9394ac5a7843f08cf12409ac9d168424.png | simple | <table><tr><td>Successful Aging Approach</td><td>Definition</td><td>References</td></tr><tr><td>Biomedical</td><td>Absence of multi-morbidity</td><td>[6]</td></tr><tr><td>Psycho-Cognitive</td><td>Absence of depression, absence of anxiety, no cognitive impairment, regular functioning, quality of life, resilience</td><td... |
9fe8545e6152550dbaaa8b03f9f6ceee74e41b643f3343d6109e9e806b5cae87.png | complex | <table><tr><td>Country and Year</td><td>Criteria used for identifying asymptomatic malaria cases</td><td>Study subjects, sample size</td><td>Follow-up protocol and duration</td><td>Ref.</td></tr><tr><td colspan="5">Africa</td></tr><tr><td>Gabon, 2003</td><td>No clinical symptoms of malaria with a <i>P. falciparum </i>p... |
36f88ed582bd0bdf0254df192a761747cd5449c424e4e174da31d02879d2fe58.png | complex | <table><tr><td rowspan="2">Samples</td><td colspan="6">Inhibition zones ± (mm)<sup>1</sup></td></tr><tr><td><i>E. coli</i>CCMB261</td><td><i>S. aureus</i> CCMB262</td><td><i>S. aureus</i> CCMB263</td><td><i>P. aeruginosa</i>CCMB268</td><td><i>C. albicans</i>CCMB286</td><td><i>C. parapsilosis</i>CCMB288</td></tr><t... |
eb5e2e7f59bdde7d9732367d5a69d92602999495c2029b1eced30faab504021f.png | complex | <table><tr><td colspan="2">Characteristics</td><td>n (<i>N</i> = 157)</td><td>%</td></tr><tr><td rowspan="4">Age</td><td><19 years</td><td>3</td><td>1.9</td></tr><tr><td>20–24 years</td><td>104</td><td>66.3</td></tr><tr><td>25–29 years</td><td>47</td><td>29.9</td></tr><tr><td>>30 years</td><td>3</td><... |
7218de6fc23796deb05334090941df9b8cdd00cda7544243685e57655abb886d.png | simple | <table><tr><td>Neonatal characteristic </td><td>Newborn-monotherapy dyadsMean (SE) or <i>n</i> (%)</td><td>Newborn-triple therapy dyadsMean (SE) or <i>n</i> (%)</td><td><i>p</i> value</td></tr><tr><td>Gender</td><td> </td><td> </td><td> </td></tr><tr><td> Male</td><td>45 (53%)</td><td>18 (49%)</td><td>NS</td></tr><tr><... |
19012ee9c3c84b5d7b35e1a9602eb0db9b9953ee8d41169cf64f8ceb01e5ffd2.png | simple | <table><tr><td>ARV site</td><td>Total number of patients</td></tr><tr><td>Thamaga primary hospital</td><td>1646</td></tr><tr><td>Nkoyaphiri clinic</td><td>1726</td></tr><tr><td>Gabane clinic</td><td>392</td></tr><tr><td>Thamaga clinic</td><td>114</td></tr><tr><td>Mmankgodi clinic</td><td>70</td></tr><tr><td>Kopong clin... |
cd8d3d47aea593f5fe2a9aee7ecef03759ea4d2e77f05fb28ec49adf7857e21a.png | complex | <table><tr><td rowspan="2">Group</td><td rowspan="2">No. mice</td><td colspan="2">Vaccine and administration</td><td rowspan="2">Anti‐HCV Abs</td><td colspan="4">Days post‐prime</td></tr><tr><td>Prime</td><td>2xboost</td><td>0</td><td>14</td><td>28</td><td>42</td></tr><tr><td></td><td></td><td></td><td></td... |
41a4403dd2ac23791690183e73205a590b7829791e63bf352de8d13363a6539c.png | complex | <table><tr><td>species</td><td>factors associated with chick-a-dee call variation</td><td>references</td></tr><tr><td rowspan="4">black-capped chickadee <i>Poecile atricapillus</i></td><td>species</td><td>[48,68–70]</td></tr><tr><td>flock</td><td>[71,72]</td></tr><tr><td>individual</td><td>[73]</td></tr><tr><td>p... |
9777079b89514aa189c6b34ee562784d3e726744c8a149303c9f2b3addc43f86.png | simple | <table><tr><td> </td><td>n</td><td>%*</td></tr><tr><td>Number of patients</td><td>635</td><td> </td></tr><tr><td>Median age at time of VIT-initiation (years) (range)</td><td>39</td><td>(5–77)</td></tr><tr><td>Male/female</td><td>322/313</td><td> </td></tr><tr><td>Results of allergy testing</td><td> </td><td> </td... |
3d5765a99720f2f2359a28bc08895fb5fe8b3e51cce6b07f66df889ce7731228.png | simple | <table><tr><td>Disease</td><td>No. withdrawals/treated patients</td><td>Inefficacy or loss of efficacy</td><td>Adverse event</td><td>Persistent remission</td><td>On-demand treatment</td><td>Patient request</td><td>Switch to canakinumab</td></tr><tr><td>AOSD</td><td>20/35</td><td>14</td><td>3</td><td>1</td><td>0</td><td... |
7ea05d0d83e6c02a09bc085c482e6576242d4223ea04c7645ed06d19d7128a77.png | complex | <table><tr><td></td><td colspan="2">Total</td><td colspan="2">Sham</td><td colspan="2">0.5 mA</td><td colspan="2">1.0 mA</td><td colspan="2">1.5 mA</td></tr><tr><td><i>N</i></td><td colspan="2">87</td><td colspan="2">22</td><td colspan="2">22</td><td colspan="2">22</td><td colspan="2">21</td></tr><tr><td>RT negative</t... |
28a316edd201c7a7c77a2c2ea7e4df584d3345c46be8e67522463e66b8c9b801.png | complex | <table><tr><td></td><td></td><td colspan="2">RF</td><td colspan="2">PCVA</td></tr><tr><td></td><td></td><td>Median</td><td>95% UI</td><td>Median</td><td>95% UI</td></tr><tr><td>Adult</td><td>No HCE</td><td>0.726</td><td>(0.721, 0.730)</td><td>0.624</td><td>(0.619, 0.631)</td></tr><tr><td></td><td>HCE</td><td>0.772</td>... |
acf975ad1fdf4552d8e866485a621850385bd0728be5f4c8dd610e35e9e9ee3f.png | complex | <table><tr><td> </td><td colspan="2">5-HT</td><td colspan="2">Motilin</td><td colspan="2">VIP</td><td colspan="2">Somatostatin</td></tr><tr><td>TDCA</td><td>−0.07</td><td>0.76</td><td>0.11</td><td>0.65</td><td>0.23</td><td>0.32</td><td>0.19</td><td>0.43</td></tr><tr><td>TCA</td><td>−0.33</td><td>0.15</td><t... |
48f30b687315d295c78ee3ac06aa071a6572227342e5fb2de4afc334919f27bd.png | simple | <table><tr><td>Variable</td><td>Elderly</td><td>Middle aged</td><td>Young</td><td>P value</td></tr><tr><td>TChol</td><td>79(44%)</td><td>161 (42%)</td><td>11(31%)</td><td>0.3</td></tr><tr><td>HDL-C</td><td>98(54%)</td><td>205(53%)</td><td>15(41%)</td><td>0.3</td></tr><tr><td>LDL-C</td><td>129 (71%)</td><td>286(74%)</td... |
28c0fc02095e218ad072c52998949988ba8ed70f0416544dd8beaa516ed6c82f.png | simple | <table><tr><td>Patients</td><td>NMO/NMOSD</td><td>MS</td></tr><tr><td>Number</td><td>20</td><td>8</td></tr><tr><td>Age</td><td>49.4 ± 3.9</td><td>43.0 ± 4.8</td></tr><tr><td>Male:Female</td><td>4:16</td><td>4:4</td></tr><tr><td>Disease duration</td><td>8.1 ± 2.0</td><td>9.9 ± 3.7</td></tr><tr><td>Re... |
b7dd328c83bb11b7a92052517ea63c053e8cd0c65d401134a2c05c2117f45829.png | complex | <table><tr><td colspan="2">% Change in relative probability of delivery with a 5-min increase in travel time<sup>a</sup></td></tr><tr><td>Delivery at any facility</td><td>−30.0</td></tr><tr><td>Public facility delivery</td><td>−28.2</td></tr><tr><td>Private facility delivery</td><td>−32.9</td></tr><tr... |
b6da2883ffba25126555130e59bd35e0c11c1afb0e58749b9bfe9a128a6e18c9.png | complex | <table><tr><td>Cell Types</td><td>Species/Cell Lines</td><td colspan="2">Melotonin Effects</td><td>Receptor Types</td><td>Melatonin Concentrations</td><td>References</td></tr><tr><td>Leydig cell</td><td>mouse</td><td>Inhibition of steroid production</td><td>Inhibition of <i>StAR</i> protein expression </td><td><i>Mt1 a... |
d898a7fdbeed8809f38d13d3b062e1f00622831fc16a569b31278c92ebc5e57b.png | simple | <table><tr><td>Demographics</td><td> </td></tr><tr><td>Mean age, years (range)</td><td>32 (11–55)</td></tr><tr><td>Male : female</td><td>43 : 8 </td></tr><tr><td>Transfusion requirements, units (range)</td><td>7 (3–12) </td></tr></table> |
5679396b595d8489393511235bd725ada18e046a2cdaecc9e3c15ee35a8babca.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">Intervention group</td><td colspan="3">Control group</td><td rowspan="2"><i>P</i> Value<sup>*</sup></td></tr><tr><td>T1<sup>a</sup></td><td>T2<sup>a</sup></td><td>T3<sup>a</sup></td><td>T1<sup>a</sup></td><td>T2<sup>a</sup></td><td>T3<sup>a</sup></td></tr><tr><td>Rural (n... |
0d9589ae9fe73710df5ce3f85b78b913668722358bb1226043fcdb482e4281ce.png | complex | <table><tr><td rowspan="2">Item</td><td colspan="2">Component</td></tr><tr><td>1</td><td>2</td></tr><tr><td>Pain</td><td>0.555</td><td>−0.162</td></tr><tr><td>Shortness of breath</td><td>0.497</td><td>−0.318</td></tr><tr><td>Weakness or lack of energy</td><td>0.547</td><td>−0.379</td></tr><tr><td>Naus... |
fc67abf3f14a53b7422e1b62d224a36bce741327aea2ccd9af1c7877836a32dd.png | simple | <table><tr><td>Variable</td><td>Current contraceptive use n (%)</td><td>Unadjusted RR (95% CI)</td><td>Adjusted RR (95% CI)</td></tr><tr><td>Age (completed years)</td><td></td><td><i>p</i> = 0.45</td><td></td></tr><tr><td> 13–19</td><td>9 (36.0)</td><td>1</td><td>−</td></tr><tr><td> 20–29</td><td>154 ... |
1bc20d0031951ef0fda30b66a68626db9ed1b77bfa0eade7046ae6aad2daa7ec.png | complex | <table><tr><td colspan="3">Measurement</td><td colspan="2">Location</td><td>Data points</td><td>Sampling rate</td></tr><tr><td>Parameter</td><td>Method</td><td>Performed by</td><td>Laboratory</td><td>Office</td><td>d<sup>-1</sup> (overall)</td><td>s<sup>-1</sup></td></tr><tr><td colspan="7"><i>Physiological</i></td></t... |
ee6abc8a1f2d293c061321c6ff7fe9ce45cd866f8aa82ea96f66c308e4a2595f.png | simple | <table><tr><td>Patient type</td><td>RCTs n (%)</td></tr><tr><td>Medical/Surgical</td><td>106 (43)</td></tr><tr><td>Medical only</td><td>56 (23)</td></tr><tr><td> Bronchiolitis</td><td>16 (6)</td></tr><tr><td> Sepsis/Shock</td><td>13 (5)</td></tr><tr><td> Asthma</td><td>8 (3)</td></tr><tr><td> Other medical</td><td>19 (... |
ff0b45f13cd4381fb7232694c99357353fd58f7da8b6f9651e671860f73c4f82.png | simple | <table><tr><td></td><td>Neoadjuvant (<i>n</i> = 80)</td><td>Adjuvant (<i>n</i> = 90)</td><td><i>P</i></td></tr><tr><td>PHS (days)</td><td>11 (7–33)</td><td>11 (5–51)</td><td>0.920<sup>a</sup></td></tr><tr><td>PHS with complications (days)</td><td>15</td><td>17</td><td>0.503<sup>b</sup></td></tr><tr><td>PHS ... |
8b98dd7edbd44c04f4a4a2f01e3eec938ea13e87e73b46e87b456a6c7d9757ba.png | complex | <table><tr><td> </td><td colspan="3">Pre-supplementation</td><td colspan="3">Post-supplementation</td></tr><tr><td>Measure</td><td>Subjects reporting GIT symptoms post-supplement (mean)</td><td>Subjects GIT symptom free post-supplement (mean)</td><td><i>P </i>value</td><td>Subjects reporting GIT symptoms post- suppleme... |
076a53d15ab6e74e8d04cd4a6802d4df7f10973e4d102359f6ea94419f09a38f.png | complex | <table><tr><td rowspan="2">Variable</td><td>Glaucoma group <i>n</i> = 8777</td><td>Control group <i>n</i> = 35,108</td><td rowspan="2"><i>p-</i>value</td></tr><tr><td><i>n</i> (%)</td><td><i>n</i> (%)</td></tr><tr><td>Age, year, (mean±SD)</td><td>59.4±13.6</td><td>59.4±13.6</td><td>1.000</td></tr><tr><td... |
ee7ab18aa0d46dbd66e44866d4ec76e061650bbe6b418b03d3722216acb3e4b3.png | simple | <table><tr><td>Municipality</td><td>% Speaking indigenous language</td><td>% Speaking Zapotec monolingual</td><td>% Speaking Zapotec monolingual</td><td>% Of 15 year-old or older who read and write in Spanish</td><td>Average number of years in school</td><td>% Of the population engaged in primary production activities<... |
cadb50118ef6e62d94cf84a57b110c778301194bebfbfdee9c24400682796c15.png | complex | <table><tr><td></td><td>Total cohort</td><td><70 years</td><td>≥70 years</td></tr><tr><td colspan="4">Demographics</td></tr><tr><td> N (%)</td><td>2280</td><td>1497 (65.7)</td><td>783 (34.3)</td></tr><tr><td> Age, mean (SD) [1]</td><td>61.1 (17.0)</td><td>52.2 (13.6)</td><td>78.2 (6.2)</td></tr><tr><td> Gender... |
71dc2b1b555fd1ad01091f7f12c500533dbf19d3fbc664c92385f53db4be5df4.png | simple | <table><tr><td> </td><td>Before</td><td>After</td></tr><tr><td><i>N</i></td><td>39249</td><td>39249</td></tr><tr><td>Analgesics (<i>N</i>, %)</td><td> </td><td> </td></tr><tr><td> Represcribed pregabalin use</td><td>—</td><td>4009 (10.2)</td></tr><tr><td> 1-2-line drugs</td><td>5416 (13.8)</td><td>3213 (8.2)</td>... |
02efd969449fda1133900ffa9cc1ae791ee732a8c42afcc6610a3c5fef6c0ddd.png | complex | <table><tr><td rowspan="2">Characteristic</td><td colspan="2">No. of wells (column %)</td><td rowspan="2"><i>p</i></td></tr><tr><td>Normoxic (<i>n</i> = 196)</td><td>Low O<sub>2</sub> (<i>n</i> = 57)</td></tr><tr><td colspan="4">Pipe type</td></tr><tr><td> No pipe</td><td>14 (7.1)</td><td>4 (7.0)</td><td>0.018∗</... |
03ece78a398e326f5ff6c96a87482441506bed89f3a2884c25381c5ba30e3ead.png | complex | <table><tr><td>Characteristic</td><td><i>n</i> = 133</td></tr><tr><td>Age (years)<sup>a</sup></td><td>67.2 ± 9.4</td></tr><tr><td colspan="2">Sex</td></tr><tr><td> Male</td><td>77</td></tr><tr><td> Female</td><td>56</td></tr><tr><td colspan="2">Diagnosis</td></tr><tr><td> Pancreatic carcinoma</td><td>49</td></tr><... |
61a9b8109563f5c3a7b5bb74b87c1d956736a6e2b62420b0d7e738dce5df48a2.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Baseline</td><td colspan="2">10% O<sub>2</sub></td><td colspan="2">Recovery</td></tr><tr><td>GFP (<i>n</i> = 4)</td><td>Cre (<i>n</i> = 6)</td><td>GFP (<i>n</i> = 4)</td><td>Cre (<i>n</i> = 6)</td><td>GFP (<i>n</i> = 4)</td><td>Cre (<i>n</i> = 6)</td></tr><tr><td colspan=... |
98279206d68c15446545e0d2fbb410b166486853c21f2294ee5aba10f16f67cb.png | simple | <table><tr><td>Markers</td><td>ADHLSC</td><td>BM-MSC [14, 15]</td><td>ASC [15]</td></tr><tr><td>CD73</td><td>98.3% (95.0–99.7)</td><td>≥95% (guideline)</td><td>≥95%</td></tr><tr><td>CD90</td><td>91.5% (86.9–95.0)</td><td>≥95% (guideline)</td><td>≥95%</td></tr><tr><td>CD105</td><td>96... |
5145d9384f6aa67cda1b6ad0db21f57d0a63d040c6ae58bea23311dc3fb32d9b.png | simple | <table><tr><td>Measure</td><td>DF</td><td><i>F</i></td><td><i>P</i></td></tr><tr><td>DASS-depression</td><td>1.61</td><td>.24</td><td>.79</td></tr><tr><td>DASS-anxiety</td><td>1.60</td><td>1.72</td><td>.19</td></tr><tr><td>DASS-stress</td><td>1.61</td><td>2.05</td><td>.14</td></tr><tr><td>DASS-total</td><td>1.60</td><t... |
df1891314c7a4dd4e3368aa870163c276b00d2751a02c4b1b69a48deb2bac6d9.png | simple | <table><tr><td>Comparison</td><td>P-value</td><td>Comparison</td><td>P-value</td></tr><tr><td>Breast/Colon</td><td>0.0001</td><td>Colon/SCC</td><td>0.135</td></tr><tr><td>Breast/SCC</td><td>0.114</td><td>Colon/KA</td><td>0.027</td></tr><tr><td>Breast/KA</td><td>0.0001</td><td>KA/SCC</td><td>0.0001</td></tr><tr><td>Brea... |
e98ff0af418732d61fcc861f2306b9feb3c471cb9cab1f015bac02e2e68c2059.png | simple | <table><tr><td></td><td>DL-CNN vs RS1</td><td>AI-CALS vs RS1</td><td>DL-CNN vs RS2</td><td>AI-CALS vs RS2</td></tr><tr><td>Average minimum distance <i>AVDIST</i></td><td></td><td></td><td></td><td></td></tr><tr><td> Pre-treatment</td><td>4.8 ± 1.8mm</td><td>5.3 ± 2.7mm</td><td>4.9 ± 3.4mm</td><td>4.5 ... |
096d7922908e0c35c1bc02398a4b3f083e2fe475b7d977c0ec3d93ca29e731e7.png | complex | <table><tr><td>Targets</td><td colspan="3">MLC leaf width</td></tr><tr><td></td><td>10 mm</td><td>4 mm</td><td><i>p </i>value</td></tr><tr><td>Pgtv</td><td></td><td></td><td></td></tr><tr><td> Dmax</td><td>7056.1 ± 127.2</td><td>6996.3 ± 88.9</td><td>0.24</td></tr><tr><td> Dmin</td><td>6035.5 ± 113.7</td... |
b311723db2e831a2b1e5d1f8a6b3f1dd2bc06dc5819f293ce53998c9b9038f4b.png | simple | <table><tr><td>Location</td><td>N</td><td>A</td><td>SD</td><td>Ho</td><td>SD</td><td>He</td><td>SD</td></tr><tr><td>Bolungarvik</td><td>11</td><td>2.08</td><td>0.79</td><td>0.24</td><td>0.21</td><td>0.29</td><td>0.25</td></tr><tr><td>Grafarvogur, Reykjavik</td><td>12</td><td>2.33</td><td>0.65</td><td>0.43</td><td>0.26<... |
b99faf885af8fe999155fbceb4bc65ecf39173d1834e8e6c43708a10e95ce429.png | complex | <table><tr><td></td><td colspan="2">Females</td><td colspan="2">Males</td><td>Unadjusted OR (95 % CI)</td><td>Adjusted OR<sup>a</sup> (95 % CI)</td></tr><tr><td></td><td>Number</td><td>Percent</td><td>Number</td><td>Percent</td><td></td><td></td></tr><tr><td>Total<sup>b</sup></td><td>3750</td><td></td><td>326</td><td><... |
5a6b6d6848733a37ef5cacc39e4bd5344cdbbfd0977aabb9b6e87b0dab0a175d.png | simple | <table><tr><td></td><td>Daily Cannabis Users</td><td>Cannabis Non-Users</td></tr><tr><td>Sample Size (N)</td><td>243</td><td>244</td></tr><tr><td>Gender</td><td>81% male; 19% female</td><td>51% male; 49% female</td></tr><tr><td>Average Age*</td><td><i>M </i>= 37.8, <i>SD </i>= 13.3</td><td>M = 28.2, <i>SD </i>= 11.0</t... |
4057718aeafec0824e6a03fa0033e9aac608b4e4ddc5ce6ccbca7f24157bb182.png | simple | <table><tr><td>Causative factors</td><td>Numbers</td></tr><tr><td>Antenatal</td><td>38 (11.7 %)</td></tr><tr><td>Intrapartum</td><td>220 (67.9 %)</td></tr><tr><td> Placental abruption</td><td>87</td></tr><tr><td> Cord prolapse</td><td>16</td></tr><tr><td> Uterine rupture</td><td>15</td></tr><tr><td> Maternal hypoxic ev... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.